All In Biotech

Drug Trial Radar · NCT04126135

Comparative Effectiveness of Cystine Versus Nicotine Replacement Therapy

Comparative Effectiveness of Cystine Versus Nicotine Replacement Therapy (NRT) in the National Smoking Cessation Program of Mongolia: A Pragmatic Non-Inferiority Trial

Last checked: Nov 20, 2026Latest source record: Sep 19, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 1,307 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,307

Actual

Start

Jan 27, 2022

Primary completion

Mar 4, 2024

Study completion Apr 20, 2024

Sponsor

Lead sponsor
Loma Linda UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Pfizer; Mongolian National University of Medical Sciences
First posted
Oct 15, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Single (investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 100 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A pragmatic, single blinded, randomized, controlled non-inferiority trial of Cytisine versus Nicotine Replacement Therapy for continuous abstinence is conducted in the government run primary health hospitals in Mongolia.

Conditions

  • Nicotine Addiction

Interventions

  • CytisineDrug

    Subjects will take a 25-day course of Cytisine tablets started during the 4 days before the quit date. They will be asked to reduce smoking during this time.

  • Nicotine Replacement Therapy (NRT)Drug

    Subjects are asked to completely stop smoking on their quit day and use a daily NRT patch for 25 days.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Length of abstinence after 25 day course of Cytisine.Time frame: One month after quit date

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Mongolian National University of Medical Sciences

    Ulaanbaatar, Mongolia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.